Stock ZEN ZENTEK LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zentek Ltd.

Equities

ZEN

CA98942X1024

Biotechnology & Medical Research

Market Closed - Toronto S.E.
Other stock markets
 03:59:59 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.48 CAD +2.07% Intraday chart for Zentek Ltd. +4.23% +2.07%
Apr. 25 Zentek Ltd. Provides ZenGUARD Business Update CI
Apr. 03 Zentek Ltd. Enters into Definitive Distribution Agreement with Medwell Solutions LLC CI

Valuation

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Capitalization 1 43.25 27.5 24.14 226.5 382.6 206
Enterprise Value (EV) 1 43.15 26.28 23.33 223.8 358.2 197.3
P/E ratio -27.4 x -10.3 x -15 x -57.1 x -9.19 x -14.3 x
Yield - - - - - -
Capitalization / Revenue - - - - 1,102,000,107 x 2,828,019,244 x
EV / Revenue - - - - 1,031,593,065 x 2,707,984,696 x
EV / EBITDA -27 x -11.1 x -15 x -53.7 x -31.1 x -14 x
EV / FCF -49.9 x -13.1 x -9.64 x -4,673 x -29.1 x -19.9 x
FCF Yield -2% -7.63% -10.4% -0.02% -3.44% -5.02%
Price to Book 1.96 x 1.1 x 0.94 x 8.26 x 11.1 x 6.78 x
Nbr of stocks (in thousands) 63,597 74,334 80,453 86,128 99,118 99,534
Reference price 2 0.6800 0.3700 0.3000 2.630 3.860 2.070
Announcement Date 7/30/18 7/12/19 7/27/20 7/28/21 6/29/22 6/29/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales - - - - 0.3472 0.0729
EBITDA 1 -1.597 -2.37 -1.553 -4.17 -11.52 -14.14
EBIT 1 -1.603 -2.375 -1.578 -4.252 -11.96 -14.52
Operating Margin - - - - -3,443.94% -19,925.32%
Earnings before Tax (EBT) 1 -1.565 -2.428 -1.541 -3.869 -12.02 -14.41
Net income 1 -1.565 -2.428 -1.541 -3.869 -38.69 -14.41
Net margin - - - - -11,145.14% -19,784.87%
EPS 2 -0.0248 -0.0361 -0.0200 -0.0460 -0.4202 -0.1450
Free Cash Flow 1 -0.8639 -2.005 -2.419 -0.0479 -12.33 -9.902
FCF margin - - - - -3,550.46% -13,591.1%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 7/30/18 7/12/19 7/27/20 7/28/21 6/29/22 6/29/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 - -0.3581 0.0481 - 0.0152
EBITDA - - - - -
EBIT 1 - -5.129 -5.053 -3.476 -3.382
Operating Margin - 1,432.31% -10,503.6% - -22,252.24%
Earnings before Tax (EBT) - - - - -
Net income -1.915 - - - -
Net margin - - - - -
EPS -0.0200 - - - -
Dividend per Share - - - - -
Announcement Date 2/28/22 6/30/22 8/5/22 11/14/22 2/10/23
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 0.1 1.22 0.81 2.69 24.4 8.75
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.86 -2 -2.42 -0.05 -12.3 -9.9
ROE (net income / shareholders' equity) -6.99% -10.3% -6.09% -14.6% -38.8% -40.1%
ROA (Net income/ Total Assets) -4.45% -6.22% -3.81% -9.41% -21.9% -23.2%
Assets 1 35.15 39.06 40.45 41.12 176.7 62.18
Book Value Per Share 2 0.3500 0.3300 0.3200 0.3200 0.3500 0.3100
Cash Flow per Share 2 0 0.0200 0.0100 0.0400 0.2700 0.1000
Capex 1 0.43 1.74 1.61 1.37 3.99 2.27
Capex / Sales - - - - 1,148.07% 3,119.81%
Announcement Date 7/30/18 7/12/19 7/27/20 7/28/21 6/29/22 6/29/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ZENTEK LTD. Stock Zentek Ltd.
+2.07% 109M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ZEN Stock
  4. Financials Zentek Ltd.